How AI Has Changed the Business of Drug Discovery - Dr. Michael Zaiac
Talking Biotech with Dr. Kevin Folta
00:00
The Impact of AI on Clinical Trial Enrollment
Speaking with Dr. Michael Ziyak, he's the head of medical affairs oncology in Novartis of Europe. We're talking about the modern changes that AI is artificial intelligence and it's active ingredients. And how is AI being used nowadays to improve patient recruitment for clinical trials? Because this is always an issue.
Transcript
Play full episode
